Serina Therapeutics

About:

Serina Therapeutics employs its proprietary polymer technology to develop treatments for cancer, inflammation, pain and metabolic disorders.

Website: http://www.serinatherapeutics.com

Top Investors: Innovate Alabama

Description:

Serina Therapeutics is a privately-held pharmaceutical company that is advancing novel therapeutics for cancer, inflammation, pain, and metabolic disorders using its proprietary polymer technology. They have created new pharmaceutical candidates using polyoxazoline (POZ), a safe, water-soluble polymer to which they can attach a variety of small molecules, proteins, peptides, and DNA. The attachment of these molecules to polymers of POZ typically confers a unique pharmacokinetic profile that is markedly different from the parent compound, and this profile may confer advantages in terms of safety and efficacy.

Total Funding Amount:

$35.7M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Huntsville, Alabama, United States

Founded Date:

2007-01-01

Contact Email:

info(AT)serinatherapeutics.com

Founders:

Michael Bentley

Number of Employees:

1-10

Last Funding Date:

2022-08-30

IPO Status:

Public

Industries:

© 2025 bioDAO.ai